Low-dose ginseng (Panax quinquefolium) modulates the course and magnitude of the antibody response to vaccination against Equid herpesvirus 1 in horses

Canadian Journal of Veterinary Research

Volumn 71, Issue 3, 2007, Pages 213-217

  Pearson, Wendy ^a   Omar, Semir ^b   Clarke, Andrew F ^c  

^a UNIVERSITY OF GUELPH   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG CARRIER; GINSENG EXTRACT; GINSENOSIDE; GINSENOSIDE RB 1; GINSENOSIDE RB 2; GINSENOSIDE RC; GINSENOSIDE RD; GINSENOSIDE RE; GINSENOSIDE RF; GINSENOSIDE RG 1; INACTIVATED VACCINE; MOLASSES; PNEUMABORT K; POTASSIUM; SODIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BIOCHEMISTRY; BLOOD ANALYSIS; BODY WEIGHT; CONTROLLED STUDY; DIET SUPPLEMENTATION; EQUINE HERPES VIRUS; FEMALE; GINSENG; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORSE DISEASE; LOW DRUG DOSE; MALE; NONHUMAN; PANAX QUINQUEFOLIUM; POTASSIUM BLOOD LEVEL; SODIUM BLOOD LEVEL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; FEMALE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, EQUID; HERPESVIRUS VACCINES; HORSE DISEASES; HORSES; MALE; PANAX; POTASSIUM; SODIUM; VACCINATION;

EQUID HERPESVIRUS 1; EQUIDAE; PANAX GINSENG; PANAX QUINQUEFOLIUS;

EID: 34547432532     PISSN: 08309000     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Carman S, Rosendal S, Huber L, et al. Infectious agents in acute respiratory disease in horses in Ontario. J Vet Diagn Invest 1997;9:17-23.
2. Mumford EL, Traub-Dargatz JL, Carman J, et al. Occurrence of infectious upper respiratory tract disease and response to vaccination in horses on six sentinel premises in northern Colorado. Equine Vet J 2003;35:72-77.
3. Gilkerson J, Jorm LR, Love DN, Lawrence GL, Whalley JM. Epidemiological investigation of Equid herpesvirus-4 (EHV-4) excretion assessed by nasal swabs taken from thoroughbred foals. Vet Microbiol 1994;39:275-283.
4. Taouji S, Collobert C, Gicquel B, et al. Detection and isolation of equine herpesviruses 1 and 4 from horses in Normandy: an autopsy study of tissue distribution in relation to vaccination status. J Vet Med 2002;49:394-399.
5. van Maanen C. Equine herpesvirus 1 and 4: an update. Vet Q 2002;24:58-78.
6. Ostlund EN. The equine herpesviruses. Vet Clin North Am Equine Pract 1993;9:283-294.
7. Smith KC, Blunden AS, Whitwell KE, Dunn KA, Wales AD. A survey of equine abortion, stillbirth and neonatal death in the UK from 1988 to 1997. Equine Vet J 2003;35:496-501.
8. Cardwell J, Smith K, Newton R, Blunden T, Bestbier M, Whitwell K. EHV paralytic disease in the south of England. Vet Rec 2003;152:441-442.
9. Bryans JT, Swerczek TW, Darlington RW, Crowe MW. Neonatal foal disease associated with perinatal infection by equine herpesvirus 1. J Equine Med Surg 1977;1:20-26.
10. Allen GP, Yeargan MR. Use of lambda gt11 and monoclonal antibodies to map the genes for the six major glycoproteins of equine herpesvirus 1. J Virol 1987;61:2454-2461.
11. Gluck R, Burri KG, Metcalfe I. Adjuvant and antigen delivery properties of virosomes. Curr Drug Deliv 2005;2:395-400.
12. Rivera E, Daggfeldt A, Hu S. Ginseng extract in aluminium hydroxide adjuvanted vaccines improves the antibody response of pigs to porcine parvovirus and Erysipelothrix rhusiopathiae. Vet Immunol Immunopathol 2003;91:19-27.
13. Rivera E, Hu S, Concha C. Ginseng and aluminium hydroxide act synergistically as vaccine adjuvants. Vaccine 2003;21: 1149-1157.
14. Sun HX, Qin F, Ye YP. Relationship between haemolytic and adjuvant activity and structure of protopanaxadiol-type saponins from the roots of Panax notoginseng. Vaccine 2005;23: 5533-5542.
15. Sun HX, Ye YP, Pan HJ, Pan YJ. Adjuvant effect of Panax notoginseng saponins on the immune responses to ovalbumin in mice. Vaccine 2004;22:3882-3889.
16. Hu S, Concha C, Lin F, Persson Waller K. Adjuvant effect of ginseng extracts on the immune response to immunization against Staphylococcus aureus in dairy cattle. Vet Immunol Immunopathol 2003;91:29-37.
17. Scaglione F, Cattaneo G, Alessandria M, Cogo R. Efficacy and safety of the standardized ginseng extract G115 for potentiating vaccination against common cold and/or influenza syndrome. Drug Exp Clin Res 1996;22:65-72.
18. Subcommittee on Horse Nutrition, Committee on Animal Nutrition, Board on Agriculture, National Research Council. Nutrient Requirements of Horses, 5th revised ed. Washington, DC: National Academy Press, 1989.
19. Olfert ED, Cross BM, McWilliams AA, eds. Guide to the Care and Use of Experimental Animals. Volume 1. Ottawa, Ontario: Canadian Council on Animal Care, 1993.
20. Gibson JS, O'Neill T, Thackray A, Hannant D, Field HJ. Serological responses of specific pathogen-free foals to equine herpesvirus-1: primary and secondary infection, and reactivation. Vet Microbiol 1992;32:199-214.
21. Assinewe VA, Baum BR, Gagnon D, Amason JT. Phytochemistry of wild populations of Panax quinquefolius L. (North American ginseng). J Agric Food Chem 2003;51:4549-4553.
22. Xu QF, Fang XL, Chen DF. Pharmacokinetics and bioavailability of ginsenoside Rb1 and Rg1 from Panax notoginseng in rats. J Ethnopharmacol 2003;84:187-192.
23. Jie YH, Cammisuli S, Baggiolini M. Immunomodulatory effects of Panax ginseng C.A. Meyer in the mouse. Agents Actions 1984; 15:386-391.
24. Liou CJ, Li ML, Tseng J. Intraperitoneal injection of ginseng extract enhances both immunoglobulin and cytokine production in mice. Am J Chin Med 2004;32:75-88.
25. Lipkowitz S, Greene WC, Rubin AL, Novogrodsky A, Stenzel KH. Expression of receptors for interleukin 2: role in the commitment of T lymphocytes to proliferate. J Immunol 1984;132:31-37.
26. Chirmule N, Kalyanaraman VS, Lederman S, et al. HIV-gp 160-induced T cell-dependent B cell differentiation. Role of T cell-B cell activation molecule and IL-6. J Immunol 1993; 150:2478-2486.
27. +)-ATPase activity. Zhongguo Yao Li Xue Bao 1990;11:10-14.
28. 2+ current by ginsenoside Re, an ingredient of Panax ginseng, in guinea-pig cardiomyocytes. Br J Pharmacol 2004;142:567-575.
29. Zhou W, Chai H, Lin PH, Lumsden AB, Yao Q, Chen CJ. Molecular mechanisms and clinical applications of ginseng root for cardiovascular disease. Med Sci Monit 2004;10:RA187-192.
30. Zhang B, Hata R, Zhu P, et al. Prevention of ischemic neuronal. death by intravenous infusion of a ginseng saponin, ginsenoside Rb(1), that upregulates Bcl-x(L) expression. J Cereb Blood Flow Metab 2006;26:708-721.
31. Forro M, Cieslar S, Ecker GL, Walzak A, Hahn J, Lindinger MI. Total body water and ECFV measured using bioelectrical impedance analysis and indicator dilution in horses. J Appl Physiol 2000;89:663-671.